A BioHealth research program selected by the French Ministry of Research and Education in the framework of the "Laboratoires d'Excellence" initiative.
EpiGenMed wants to foster the best BioHealth basic and clinical research and to encourage interdisciplinary projects. The EpiGenMed project was selected by the French Ministry of Research and Education in the framework of the national "Investments for the Future" program in 2011. The project received 12 million euros in funding for a 10-year period, essentially devoted to science training through the recruitment of PhD students, post-doctoral fellows and Chairs of Excellence.
EpiGenMed involves 57 of the best research groups in Montpellier, implicated in five areas of research that cover Genome and Epigenome Dynamics, Cell cycle, Cell fate and Development, Infectious diseases and Immunology, Cell signalling and Neurobiology, Biophysics and Systems biology. It is hosted by the University of Montpellier and national science institutions and benefits from an excellent industrial environment
Montpellier is awarded the Label I-SITE
Postdoctoral Program 2016
The Labex (Laboratory of Excellence) EpiGenMed is a collaborative health science research program at the University of Montpellier that is financed by the Excellence Initiative of the French Ministry of Research and that involves leading research laboratories of the area.
Five major axes of research (involving 55 top-level research groups) are supported by this initiative:
• Genome and Epigenome
• Cell Cycle, Cell Fate and Development
• Infection and immunity
• Integrating Systems in Neuroscience
• Biophysics and Systems Biology
The EpiGenMed post-doctoral program offers 12 fellowships for a period of 2 years (1 year renewable), starting between January 1st, 2017 and December 1st, 2017.
The EpiGenMed research group leaders will select their candidate who has to be validated by the Labex EpiGenMed Scientific Committee.
Applications should be send directly to the following team leaders.